{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:35:23Z","timestamp":1794627323831,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,6]],"date-time":"2027-06-06T00:00:00Z","timestamp":1812240000000},"content-version":"am","delay-in-days":187,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA232845"],"award-info":[{"award-number":["R01CA232845"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA294557"],"award-info":[{"award-number":["R01CA294557"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE029237"],"award-info":[{"award-number":["R01DE029237"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P30CA093373"],"award-info":[{"award-number":["P30CA093373"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01CA314229"],"award-info":[{"award-number":["R01CA314229"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB035416"],"award-info":[{"award-number":["R01EB035416"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R43CA272110"],"award-info":[{"award-number":["R43CA272110"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB033677"],"award-info":[{"award-number":["R01EB033677"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016257","name":"University of California Davis School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124361","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:46:56Z","timestamp":1780415216000},"page":"124361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Towards the clinical translation of a novel autophagy inhibitor: Bisaminoquinoline derivative nanoparticles"],"prefix":"10.1016","volume":"335","author":[{"given":"Sohaib","family":"Mahri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1203-4473","authenticated-orcid":false,"given":"Menghuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8660-7465","authenticated-orcid":false,"given":"Edward Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-646X","authenticated-orcid":false,"given":"Yuanpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2026.124361_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124361_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124361_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/curroncol29030141","article-title":"Autophagy agents in clinical trials for cancer therapy: a brief review","volume":"29","author":"Mohsen","year":"2022","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","article-title":"Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124361_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","article-title":"Autophagy in health and disease: a comprehensive review","volume":"104","author":"Saha","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124361_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"44","author":"Jain","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124361_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400607","article-title":"Nanomedicine approaches for autophagy modulation in cancer therapy","volume":"5","author":"Mahri","year":"2025","journal-title":"Small Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124361_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/15548627.2021.1988357","article-title":"GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions","volume":"18","author":"Brun","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2026.124361_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128272","article-title":"Anticancer properties of bisaminoquinolines with modified linkers","volume":"49","author":"Wang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124361_bib10","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.1118193109","article-title":"Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency","volume":"109","author":"McAfee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib11","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/s41467-020-18399-4","article-title":"Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy","volume":"11","author":"Ma","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and art of developing lipid nanoparticles for biologics delivery: focus on development and Scale-Up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124361_bib14","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","article-title":"The effect of surface charge on in vivo biodistribution of PEG-Oligocholic acid based micellar nanoparticles","volume":"32","author":"Xiao","year":"2011","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124361_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124361_bib16","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124361_bib17","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124361_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/17435889.2025.2500906","article-title":"Immunomodulatory nanoplatforms with multiple mechanisms of action in cancer treatment","volume":"20","author":"Villa","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2026.124361_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124361_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1039\/D3LC00821E","article-title":"Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities","volume":"24","author":"Mehraji","year":"2024","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/0008-5472.CAN-12-2071","article-title":"Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors","volume":"73","author":"Huo","year":"2013","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124361_bib22","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.biomaterials.2026.124361_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","article-title":"Applications and challenges of ultra-small particle size nanoparticles in tumor therapy","volume":"353","author":"Xu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124361_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acscentsci.9b01139","article-title":"Size-tunable strategies for a tumor targeted drug delivery system","volume":"6","author":"Yu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40820-025-01717-0","article-title":"Multifunctional and scalable nanoparticles for bimodal image-guided phototherapy in bladder cancer treatment","volume":"17","author":"Tang","year":"2025","journal-title":"Nano-Micro Lett."},{"issue":"44","key":"10.1016\/j.biomaterials.2026.124361_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202101633","article-title":"Protein engineering strategies for improved pharmacokinetics","volume":"31","author":"Rondon","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124361_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124361_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10600","article-title":"PEGylated therapeutics in the clinic","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124361_bib29","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124361_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid nanoparticles: composition, formulation, and application","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124361_bib31","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124361_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biomaterials.2026.124361_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ifset.2022.103155","article-title":"Effect of phospholipids on membrane characteristics and storage stability of liposomes","volume":"81","author":"Song","year":"2022","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.biomaterials.2026.124361_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124361_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijbiomac.2020.12.108","article-title":"Protein Corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review","volume":"169","author":"Kopac","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124361_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/v15030668","article-title":"Research advances on the stability of mRNA vaccines","volume":"15","author":"Cheng","year":"2023","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124361_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910603","article-title":"Comprehensive optimization of a freeze-drying process achieving enhanced long-term stability and in vivo performance of lyophilized mRNA-LNPs","volume":"25","author":"Alejo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124361_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125272","article-title":"Formulation screening of lyophilized mRNA-lipid nanoparticles","volume":"671","author":"Ruppl","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124361_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124880","article-title":"Impact of protein aggregation on the immunogenicity of a human monoclonal antibody following pulmonary administration in mice","volume":"667","author":"Mahri","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124361_bib40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.xphs.2024.12.013","article-title":"Recent advances in drying and development of solid formulations for stable mRNA and siRNA lipid nanoparticles","volume":"114","author":"Arte","year":"2025","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.biomaterials.2026.124361_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2026.124361_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124361_bib43","first-page":"4285","article-title":"Characterization of the p53 tumor suppressor pathway in cell lines of the national cancer institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents","volume":"57","author":"O'Connor","year":"1997","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124361_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance","volume":"6","author":"Szak\u00e1cs","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124361_bib45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/mol.107.041178","article-title":"Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan","volume":"73","author":"Liao","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124361_bib46","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/onc.2012.292","article-title":"Cancer-associated lysosomal changes: friends or foes?","volume":"32","author":"Kallunki","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124361_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124361_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124361_bib49","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1073\/pnas.1411499111","article-title":"Investigating the optimal size of anticancer nanomedicine","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124361_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:17:27Z","timestamp":1785359847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226003856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S0142961226003856"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124361","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards the clinical translation of a novel autophagy inhibitor: Bisaminoquinoline derivative nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124361"}}